特应性皮炎与静脉血栓栓塞风险:英国初级保健匹配队列分析
基于英国Optimum Patient Care Research Database(2010-2020)的匹配队列研究,纳入150 975例成人活动性AD和603 770例年龄性别匹配对照。AD患者VTE风险轻度升高(aHR 1.17,95%CI 1.12-1.22),DVT风险升高(aHR 1.30,95%CI 1.23-1.37),PE风险无显著差异(aHR 0.94,95%CI 0.87-1.02)。
要点
- AD患者VTE风险轻度升高(aHR 1.17,95%CI 1.12-1.22),主要为DVT风险升高。
- AD与DVT风险升高相关(aHR 1.30,95%CI 1.23-1.37),与PE风险无显著差异(aHR 0.94,95%CI 0.87-1.02)。
- VTE风险在老年(≥65岁:aHR 1.22,95%CI 1.15-1.29)和肥胖(BMI≥30:aHR 1.25,95%CI 1.12-1.39)AD患者中更高。
核心结论
- AD与VTE和DVT风险轻度升高相关,PE风险无升高。
- 年轻和无肥胖者风险增加幅度较小。
研究设计与样本
- 基于英国Optimum Patient Care Research Database(2010年1月1日至2020年1月1日)的匹配队列分析。
- 纳入150 975例成人活动性AD患者,与603 770例年龄性别匹配对照比较。
- 使用Cox比例风险模型比较VTE(PE或DVT)风险,PE和DVT分别作为次要结局分析。
主要发现
- 研究期间,活动性AD患者中2576例发生VTE,匹配对照中7563例发生VTE。
- AD患者VTE风险高于对照(aHR 1.17,95%CI 1.12-1.22)。
- AD与DVT风险升高相关(aHR 1.30,95%CI 1.23-1.37),与PE风险无显著差异(aHR 0.94,95%CI 0.87-1.02)。
- VTE风险在老年AD患者中更高(≥65岁:aHR 1.22,95%CI 1.15-1.29;45-65岁:aHR 1.15,95%CI 1.05-1.26;<45岁:aHR 1.07,95%CI 0.97-1.19)。
- VTE风险在肥胖AD患者中更高(BMI≥30:aHR 1.25,95%CI 1.12-1.39;BMI<30:aHR 1.08,95%CI 1.01-1.15)。
临床怎么用
- AD患者VTE风险轻度升高,以DVT为主,PE风险无升高。
- 老年和肥胖AD患者VTE风险增加更明显。
- 风险增加幅度在年轻和无肥胖者中较小。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Atopic dermatitis (AD) is a common chronic inflammatory skin condition. While other chronic inflammatory conditions are associated with increased risk of venous thromboembolism (VTE), associations between AD and VTE have not been established. OBJECTIVES: We examined whether AD is associated with an increased risk of VTE in a population-based study. METHODS: Electronic health records were extracted from UK general practices contributing to the Optimum Patient Care Research Database (1 January 2010 to 1 January 2020). All adults with AD were identified (n = 150 975) and age- and sex-matched with unaffected controls (n = 603 770). The risk of VTE, consisting of pulmonary embolism (PE) or deep-vein thrombosis (DVT), was compared in people with AD vs. controls using Cox proportional hazard models. PE and DVT were examined separately as secondary outcomes. RESULTS: We identified 150 975 adults with active AD and matched them with 603 770 unaffected controls. During the study, 2576 of those with active AD and 7563 of the matched controls developed VTE. Individuals with AD had a higher risk of VTE than controls [adjusted hazard ratio (aHR) 1.17, 95% confidence interval (CI) 1.12-1.22]. When assessing VTE components, AD was associated with a higher risk of DVT (aHR 1.30, 95% CI 1.23-1.37) but not PE (aHR 0.94, 95% CI 0.87-1.02). The VTE risk was greater in older people with AD (≥ 65 years: aHR 1.22, 95% CI 1.15-1.29; 45-65 years: aHR 1.15, 95% CI 1.05-1.26; < 45 years: aHR 1.07, 95% CI 0.97-1.19) and those with obesity [body mass index (BMI) ≥ 30: aHR 1.25, 95% CI 1.12-1.39; BMI < 30: aHR 1.08, 95% CI 1.01-1.15). Risk was broadly consistent across mild, moderate or severe AD. CONCLUSIONS: AD is associated with a small increase in risk of VTE and DVT, with no increase in risk of PE. The magnitude of this risk increase is modest in younger people, and those without obesity.
引用
- Warren RB, Basey V, Lynam A, et al. The risk of venous thromboembolism in atopic dermatitis: a matched cohort analysis in UK primary care. Br J Dermatol. 2023. PMID: 37418627. doi:10.1093/bjd/ljad212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。